In the development of sporadic colon cancer, activation of the PI3K/AKT and Ras/Raf (acronym for rapidly accelerated fibrosarcoma)/MEK (MAPK/ERK kinase)/MAPK (mitogen-activated protein kinase) pathways are usually implicated. This evidence concerns the gene AKT1 and malignant colon neoplasm.